CCC
EMN icon

Crescent Capital Consulting’s Eastman Chemical EMN Stock Holding History

Crescent Capital Consulting’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-522
Closed -$57K – 499
2021
Q1 		$57K Buy
+522
New +$56.7K 0.01% 271

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Crescent Capital Consulting's EMN Position: Q2 2021 in Review

Crescent Capital Consulting sold out of Eastman Chemical (EMN) in Q2 2021, closing a stake of 522 shares — an estimated $57K sold.

Crescent Capital Consulting first reported a position in EMN in Q1 2021 and held it in 1 quarter. The position peaked at $57K in Q1 2021. 723 funds tracked by Wall St. Rank hold EMN as of Q2 2021.

  • Crescent Capital Consulting reported no remaining Eastman Chemical position as of Q2 2021 after selling out during the quarter.
  • Crescent Capital Consulting sold 522 Eastman Chemical shares in Q2 2021, an estimated $57K.
  • Crescent Capital Consulting first reported a position in Eastman Chemical in Q1 2021 and held it in 1 quarter.
  • Crescent Capital Consulting's Eastman Chemical position peaked at $57K in Q1 2021.
  • 723 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2021.

Based on Crescent Capital Consulting's 13F filing for Q2 2021, filed 15 Jul 2021.